The problem is very simple: DECN’s partners didn
Post# of 11802
(Total Views: 336)
Posted On: 03/23/2020 12:09:46 PM
The problem is very simple: DECN’s partners didn’t get their hands on a sample of COVID infected blood until last week.
Last week. More specifically, as of the PR on the 16th, DECN’s partners were “still awaiting the release of Covid blood samples.”
The technology was “Validated” by “R&D in Daegu,” purportedly on the 18th (or that’s when the PR was released.. close enough).
The 18th.
So they got it sometime between the 16th and 18th, and “Validated” the test within hours.
Anyone here ever take even an introductory microbiology class? Anyone here have an inkling about viral structure? Anyone here understand, precisely, how this test works? (Not you, Pluto.)
DECN has just “doubled down” today... setting up the Korean partners for all the blame.. “DECN announces that the company, through its advanced development team in Korea, have finalized configuration of the [genviro swift kit test strip, yadda yadda].”
Nobody, still, knows the problem here? One more hint... March 11 PR:
“Our biggest challenge will be meeting demand.”
Understatement of the decade (It’s still early, I think it’s a contender). Like I’ve said before, its not like flipping a switch and the strips come flying right out.
I think KB’s very aware of the issue. I think he’s parsing words carefully because of it. I’m not sure if the Axis of Pluto doesn’t see the issue or is pretending to not know what it is to let their hedge friend’s short this at higher levels. But we have another PR without any discussion of hard numbers for accuracy / minimum viral concentrations / anything data-based. That can’t be a mistake (rather, it’s a plausible deniability ploy).
I never say anything positive? Sorry, here.. I’ve said for weeks now PCR is borderline useless; I’m glad KB agrees. Antibody/antigen is also less than optimal, I agree.
Anyway, DECN has until Wednesday to put some real data out. I’ll be laying everything out so even Pluto could understand it, if they don’t.
Last week. More specifically, as of the PR on the 16th, DECN’s partners were “still awaiting the release of Covid blood samples.”
The technology was “Validated” by “R&D in Daegu,” purportedly on the 18th (or that’s when the PR was released.. close enough).
The 18th.
So they got it sometime between the 16th and 18th, and “Validated” the test within hours.
Anyone here ever take even an introductory microbiology class? Anyone here have an inkling about viral structure? Anyone here understand, precisely, how this test works? (Not you, Pluto.)
DECN has just “doubled down” today... setting up the Korean partners for all the blame.. “DECN announces that the company, through its advanced development team in Korea, have finalized configuration of the [genviro swift kit test strip, yadda yadda].”
Nobody, still, knows the problem here? One more hint... March 11 PR:
“Our biggest challenge will be meeting demand.”
Understatement of the decade (It’s still early, I think it’s a contender). Like I’ve said before, its not like flipping a switch and the strips come flying right out.
I think KB’s very aware of the issue. I think he’s parsing words carefully because of it. I’m not sure if the Axis of Pluto doesn’t see the issue or is pretending to not know what it is to let their hedge friend’s short this at higher levels. But we have another PR without any discussion of hard numbers for accuracy / minimum viral concentrations / anything data-based. That can’t be a mistake (rather, it’s a plausible deniability ploy).
I never say anything positive? Sorry, here.. I’ve said for weeks now PCR is borderline useless; I’m glad KB agrees. Antibody/antigen is also less than optimal, I agree.
Anyway, DECN has until Wednesday to put some real data out. I’ll be laying everything out so even Pluto could understand it, if they don’t.
(0)
(1)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼